Clinical Trials Logo
NCT number NCT03182933
Study type Interventional
Source University of Wisconsin, Madison
Contact Hubert Cios, MD
Phone 8477124414
Email cios@wisc.edu
Status Recruiting
Phase Phase 4
Start date May 30, 2017
Completion date December 31, 2018

Clinical Trial Summary

Study will evaluate the effect of liposomal bupivacaine versus standard bupivacaine on physical therapy measures and pain scores as well as opiate consumption.


Clinical Trial Description

Total knee arthroplasty (TKA) can be associated with a large amount of postoperative pain. This pain can oftentimes be severe enough to limit participation in physical therapy and ultimately delay discharge resulting in increased cost. Several strategies have been developed in an effort to decrease postoperative pain following TKA while maintaining lower extremity strength and maximizing participation in physical therapy. Recently, adductor canal blockade has gained popularity as it is reported to provide analgesia to the anterior knee without resulting in significant quadriceps muscle weakness. One downside of single shot peripheral blockade is the duration of analgesia can oftentimes be short lived. The advent of depot local anesthetics has made this an attractive option, especially in busy practices where placing peri-neural catheters may not be practical or cost effective. This study aims to carefully evaluate this relationship using a physical therapy evaluation method that relies on both motor strength and pain control. In addition, we hope to carefully evaluate motor strength using a novel method of strength measurement in an effort to further evaluate the impact of depot local anesthetic injection into the adductor canal on physical therapy and analgesia.


Study Design


Related Conditions & MeSH terms


See also
Status Clinical Trial Phase
 Completed NCT01441141 - Genetics and Pain Severity in Sickle Cell Disease N/A
 Completed NCT02913027 - Can We Improve the Comfort of Pelvic Exams? N/A
 Terminated NCT02181387 - Acetaminophen Use in Labor - Does Use of Acetaminophen Reduce Neuraxial Analgesic Drug Requirement During Labor? N/A
 Completed NCT01077414 - Phenomenological Study of Psycho-Socio-Spiritual Healing in the Context of Chronic or Life-Threatening Illness N/A
 Completed NCT01198197 - PET Brain and Whole Body Distribution Studies for Nociceptin/Orphanin FQ Peptide (NOP) Receptor Using [11C]NOP-1A Early Phase 1
 Recruiting NCT02913833 - The Impact of Pain Assessment on the Hospital Length of Stay of Patients in a Rehabilitation Unit N/A
 Recruiting NCT02911168 - Comparison of US-Guided Paravertebral and Proximal Intercostal Nerve Blocks N/A
 Recruiting NCT02839889 - Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation) Phase 4
 Recruiting NCT02943772 - Does Local Cooling of Testis in Patients With Epididymitis Relieve Pain and Reduce Quantity of Analgetics Intake? N/A
 Recruiting NCT02917603 - Shared Decision Making to Improve Palliative Care in the Nursing Home N/A
 Recruiting NCT02829736 - ThOracoscopic Wedge Resection Treated With Chest Tube Removal Intraoperatively N/A
 Recruiting NCT02885051 - Evaluation of Pain in Preterm Newborn N/A
 Completed NCT02876705 - Spatiotemporal Patterns of Pain During Exercise Phase 0
 Not yet recruiting NCT02840942 - Robots to Reduce Pain During IV Placement N/A
 Not yet recruiting NCT02834481 - Assessment of Pain Monitoring With ANI/NIPE Monitor Program in Pediatric Cardiac Surgery Postoperative. Phase 4
 Completed NCT02916927 - Intravenous Sub-dissociative Dose Ketamine Injection Versus Infusion for Analgesia in the Emergency Department Phase 4
 Not yet recruiting NCT02840838 - Botulinum Toxin for Post Abdominoplasty Pain Control Phase 4
 Not yet recruiting NCT02851940 - Pain and Bleeding Following Hypertonic Saline Sclerotherapy Compared to Brand Ligation for Symptomatic Hemorrhoids N/A
 Not yet recruiting NCT02854553 - TAP Block Alone Versus TAPblock With Rectus Sheath Block in Liposuction Surgery N/A
 Not yet recruiting NCT02847013 - The Use of Liposomal Bupivacaine in TAP Blocks for Women Undergoing Cesarean Section Phase 2/Phase 3